Secteur CNS Pharmaceuticals, Inc.

Actions

CNSP

US18978H5081

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq 22:00:00 29/06/2026 Varia. 5j. Varia. 1 janv.
4,150 USD +4,27% Graphique intraday de CNS Pharmaceuticals, Inc. -3,04% -20,95%
Principaux concurrents
Varia. Varia. 5j. Variation 1 mois Variation 3 mois Varia. 1 janv. Varia. 1an Varia. 3ans Varia. 5ans Varia. 10ans Capi.($)
+4,27%-3,04%-23,71%+70,08%-20,95%-60,66%-99,99%-100,00% - 6,07 M
+2,19%-1,23%+11,84%+31,00%+12,03%+70,92%+125,94%+214,78%+6 943,86% 55,78 Md
+6,76%+18,10%+24,18%+30,07%+39,20%+91,66%+104,09%-20,13% - 55,66 Md
+3,33%+4,51%-1,76%+10,01%-0,99%-11,68%-11,91%-58,67% - 23,84 Md
+1,32%+6,22%-2,03%-27,91%-39,82%+5,28%+415,45%+256,62%+960,12% 22,7 Md
+6,78%+7,55%+12,11%+8,82%-9,35%+39,73%-28,78%-28,39%+51,86% 16,12 Md
-0,89%+5,71%+7,53%+30,70%+23,84%+24,30%+186,29%+202,40%+595,90% 13,64 Md
+9,96%+15,98%+36,56%+98,44%+170,21%+157,65%+310,89%+1 527,44%+595,29% 14,8 Md
+2,85%+2,81%+6,03%+3,25%-9,45%+75,32%+139,44%+442,47% - 12,16 Md
+6,17%+10,22%+13,68%+39,62%+37,33%+163,15%+166,44%+313,16%+827,31% 11,85 Md
+2,04%-1,83%+3,32%+39,32%+21,25%+400,62%+124,05%-1,23%+1 387,99% 11,34 Md
+2,21%+0,28%-18,36%-13,63%-18,12%-30,49%+470,52%+92,73%+77,01% 11,11 Md
-0,01%+0,07%+11,89%+27,78%+22,79%+55,01%+188,31% - - 9,76 Md
+0,69%+21,47%+16,62%+18,83%+342,93%+224,81%+222,43%-39,68% - 9,19 Md
+2,12%+10,77%+12,30%+8,58%+25,10%+77,16%+18,99%+155,62% - 8,33 Md
+2,58%-10,13%+22,67%+90,57%+175,21%+492,38%+813,01%-49,77%-31,04% 7,83 Md
+0,40%-1,56%-2,13%+15,43%+5,76%+17,12%+56,91%+3,00%+237,24% 7,11 Md
+9,85%+13,58%-3,20%-11,77%-36,94% - - - - 7,56 Md
+0,37%+11,73%+11,48%+29,01%+24,77%+53,48%+702,34%+92,84% - 6,59 Md
+1,68%+8,09%+10,81%+7,31%+9,07%+445,63%+234,83%+383,04% - 6,62 Md
Moyenne +3,24%+6,09%+7,49%+25,28%+38,69%+120,60%+217,86%+188,12%+1 164,55% 15,6 Md
Moyenne pondérée par Capi. +3,68%+7,04%+11,16%+23,44%+31,81%+97,82%+183,74%+183,29%+2 639,48%
Médicaments bio-thérapeutiques
  1. Bourse
  2. Actions
  3. Action CNSP
  4. Secteur CNS Pharmaceuticals, Inc.